May 2004
Volume 45, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2004
Isolation and identification of a secreted protease from Pseudomonas aeruginosa
Author Affiliations & Notes
  • M.E. Marquart
    Microbiology, Immunology & Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA
  • A.R. Caballero
    Microbiology, Immunology & Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA
  • B.A. Thibodeaux
    Microbiology, Immunology & Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA
  • R.J. O'Callaghan
    Microbiology, Immunology & Parasitology, Louisiana State University Health Sciences Center, New Orleans, LA
  • Footnotes
    Commercial Relationships  M.E. Marquart, None; A.R. Caballero, None; B.A. Thibodeaux, None; R.J. O'Callaghan, None.
  • Footnotes
    Support  NIH Grant EY12961 and EY13651
Investigative Ophthalmology & Visual Science May 2004, Vol.45, 4971. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      M.E. Marquart, A.R. Caballero, B.A. Thibodeaux, R.J. O'Callaghan; Isolation and identification of a secreted protease from Pseudomonas aeruginosa . Invest. Ophthalmol. Vis. Sci. 2004;45(13):4971.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: Pseudomonas aeruginosa is a major cause of bacterial keratitis, primarily due to its production of secreted proteases that destroy host defenses and degrade the cornea. Strain PA103 is deficient in elastase, LasA, and alkaline protease. A PA103 mutant deficient in protease IV has been shown to retain reduced, yet significant, corneal virulence. These results suggest that another protease could exist, providing an additional mechanism of corneal virulence. Methods: P. aeruginosa strain PA103 was grown to stationary phase and its secreted products were analyzed for protease activity. Analyses included determination of caseinase activity by measuring the lysis of a fluorescence–labeled casein substrate in the presence and absence of potential inhibitors, and gelatin zymography to visualize the molecular mass of the protease. A protease with a unique molecular mass on zymograms was purified by ion–exchange chromatography, and mass spectrometry and amino–terminal sequencing were performed. Results: The culture supernatant of PA103 contained a protease that caused degradation of casein in the presence of a serine protease inhibitor, but was inhibited by EDTA. Gelatin zymograms showed protease activity at >200 kDa (protease IV) and at about 80 kDa. The protease with zymogram activity at 80 kDa, after purification, was determined by mass spectrometry to have a native mass of 18.5 kDa. The amino–terminal sequence of this protease matched the sequence of a hypothetical protein in the P. aeruginosa genome database (www.pseudomonas.com). Conclusion: P. aeruginosa PA103, in addition to protease IV, produces a protease that is susceptible to an inhibitor of metalloproteases.

Keywords: bacterial disease • keratitis • Pseudomonas 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×